ELITE Program
- Program Objective
- To strengthen practical BD and commercialization capabilities of Korean pharma/biotech companies through webinar-based training.
- Program Details
- Target participants: Professionals involved in BD, licensing, strategy, finance, IR, and global partnering at domestic pharma and biotech companies.
- Program components: A series of practical, webinar-based sessions designed to support BD professionals with actionable insights and real-world knowledge across key areas such as licensing, valuation, deal structuring, and global partnering.
- Date & Venue: May 2026 - May 2027, Venue: Online webinar
- [1st Webinar: Global BD Strategy: Sell-side & Buy-side Perspectives]
- Date & Time: Jun 4, 2026 | 3:30-5:30 PM
- Title: Global BD Strategy: Sell-side & Buy-side Perspectives
- Subtitle: Building BD Strategies Through Risk Assessment and Data Interpretation Across the Drug Development Lifecycle
- Session Summary: This session explores the risks and key data across the entire drug development value chain, interpreting the data from both sell-side and buy-side BD perspectives to develop practical and actionable deal preparation strategies.
* Details for the second and third webinars will be announced separately.
- Contact
Business Development Team: kddf_bd@kddf.org